1-(4-氟苯基)乙烯基硼酸频哪醇酯 | 850567-55-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(4-氟苯基)乙烯基硼酸频哪醇酯
• 中文别名: 1-(4-氟苯基)乙烯基硼酸频哪酯
• 英文名称: 2-(1-(4-fluorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• 英文别名: 1-(4-fluorophenyl)vinylboronic acid pinacol ester；2-[1-(4-fluorophenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• CAS: 850567-55-4
• 化学式: C₁₄H₁₈BFO₂
• mdl: MFCD06659925
• 分子量: 248.105
• InChiKey: BNROZDXKAQJDJC-UHFFFAOYSA-N

物化性质

• 熔点：
  38-42
• 沸点：
  277.8±42.0 °C(Predicted)
• 密度：
  1.04±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.94
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934999090
• 储存条件：
  -20°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
1-(4-Fluorophenyl)vinylboronic acid, pinacol ester
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
1-(4-Fluorophenyl)vinylboronic acid, pinacol ester
Ingredient name:
CAS number: 850567-55-4

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C14H18BFO2
Molecular weight: 248.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(4-氟苯基)乙烯基硼酸频哪醇酯 在 sodium periodate 、 四氧化锇 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 ammonium acetate 、 potassium carbonate 、 N-甲基吗啉氧化物 作用下， 以 四氢呋喃 、 aq. phosphate buffer 、 二氯甲烷 、 水 、 二甲基亚砜 、 丙酮 、 甲苯 为溶剂， 反应 4.17h， 生成 4-氟二苯甲酮
  参考文献：
  名称：

  Suzuki coupling of aroyl-MIDA boronate esters – A preliminary report on scope and limitations

  摘要：

  DOI：

  10.1016/j.tetlet.2021.153147
• 作为产物：
  描述：

  4-氟苯乙炔 在 1,3-bis[(diphenylphosphino)propane]dichloronickel(II) 作用下， 以 四氢呋喃 为溶剂， 反应 26.08h， 生成 1-(4-氟苯基)乙烯基硼酸频哪醇酯
  参考文献：
  名称：

  通过 Pd(II)-催化的硫醚导向的烯基 C-H 烯化反应合成基于共轭二烯的轴向手性苯乙烯

  摘要：

  共轭二烯的有效立体选择性合成，尤其是具有轴向手性的那些，仍然是一个巨大的挑战。在此，我们报告了通过 Pd(II) 催化的硫醚导向的烯基 C-H 烯化策略，高阻转选择性合成轴向手性苯乙烯与共轭 1,3-二烯支架。该策略具有操作简单、反应条件温和、官能团耐受性高（69例）、完整的Z-选择性和出色的对映选择性（高达 99% ee）。值得注意的是，使用这种策略也实现了具有两个立体轴的阻转异构体的高度对映选择性合成（高达 99% ee 和 97:3 dr）。此外，该反应可以扩大规模，所得轴向手性苯乙烯可以很容易地氧化成具有高非对映选择性的手性亚砜衍生物，这作为一种新型的硫-烯烃配体显示出巨大的前景。

  DOI：

  10.1021/jacs.1c06236

文献信息

• [EN] NOVEL THYROMIMETICS<br/>[FR] NOUVEAUX THYROMIMÉTIQUES
  申请人：AUTOBAHN THERAPEUTICS INC

  公开号：WO2021108549A1

  公开（公告）日：2021-06-03

  Compounds are provided having the structure of Formula (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein R1, R2, X1, X2, Y1, and Y2 are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.

  提供具有Formula (I)结构或其药学上可接受的异构体、拉克酸盐、水合物、溶剂化合物、同位素或盐的化合物，其中R1、R2、X1、X2、Y1和Y2如本文所定义。这些化合物作为甲状腺类似物发挥作用，并可用于治疗神经退行性疾病和纤维化疾病等疾病。还提供含有这些化合物的药物组合物，以及它们的使用和制备方法。
• [EN] N-(HETEROCYCLYL AND HETEROCYCLYLALKYL)-3-BENZYLPYRIDIN-2-AMINE DERIVATIVES AS SSTR4 AGONISTS<br/>[FR] DÉRIVÉS DE N-(HÉTÉROCYCLYL ET HÉTÉROCYCLYLALKYL)-3-BENZYLPYRIDIN-2-AMINE SERVANT D'AGONISTES DE SSTR4
  申请人：TAKEDA PHARMACEUTICALS CO

  公开号：WO2021202775A1

  公开（公告）日：2021-10-07

  Disclosed are compounds of Formula (1), and pharmaceutically acceptable salts thereof, wherein n, R1, R4, R5, R6, R7, R8, R9, R10, R11, R14, X2, X3 and X12 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula (1), to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with SSTR4.

  披露了公式（1）的化合物，以及其中n、R1、R4、R5、R6、R7、R8、R9、R10、R11、R14、X2、X3和X12在说明书中定义的药用可接受盐。本公开还涉及用于制备公式（1）化合物的材料和方法，含有它们的药物组合物，以及它们用于治疗与SSTR4相关的疾病、障碍和状况。
• Synthesis of Alkenylboronates from <i>N</i>-Tosylhydrazones through Palladium-Catalyzed Carbene Migratory Insertion
  作者：Yifan Ping、Rui Wang、Qianyue Wang、Taiwei Chang、Jingfeng Huo、Ming Lei、Jianbo Wang

  DOI：10.1021/jacs.1c02331

  日期：2021.7.7

  The palladium-catalyzed oxidative borylation reaction of N-tosylhydrazones has been developed. The reaction features mild conditions, broad substrate scope, and good functional group tolerance. It thus represents a highly efficient and practical method for the synthesis of di-, tri-, and tetrasubstituted alkenylboronates from readily available N-tosylhydrazones. One-pot Suzuki coupling and other transformations

  已经开发了钯催化的N-甲苯磺酰腙的氧化硼化反应。该反应具有条件温和、底物范围广、官能团耐受性好等特点。因此，它代表了一种从容易获得的N-甲苯磺酰腙合成二、三和四取代的烯基硼酸酯的高效和实用的方法。一锅 Suzuki 耦合和其他转换突出了该方法的综合效用。DFT 计算表明，钯-卡宾的形成和随后的硼基迁移插入是催化循环中的关键步骤。在三取代的链烯基硼酸酯形成过程中观察到的高立体选择性可以通过变形相互作用分析和 NBO 分析来解释。
• 一类具有BRD4抑制活性的化合物、其制备方法及用途
  申请人：上海海和药物研究开发股份有限公司

  公开号：CN112625036A

  公开（公告）日：2021-04-09

  本发明公开了一种具有BRD4抑制活性的化合物、其制备方法及用途。本发明的具有BRD4抑制活性的化合物，结构如式I所示，各取代基的定义如说明书和权利要求书所述。本发明的化合物，具有很高的溴结构域蛋白抑制活性，特别是靶向BRD4的抑制活性，可用于治疗或/和预防由溴结构域蛋白介导的相关疾病。
• 异喹啉酮类化合物及其应用
  申请人：四川科伦博泰生物医药股份有限公司

  公开号：CN108341777A

  公开（公告）日：2018-07-31

  本发明涉及一种异喹啉酮类化合物及其应用。具体来说，本发明涉及一种作为HIF脯氨酰羟化酶抑制剂的异喹啉酮类化合物及其药物组合物。而且，本发明还提供了上述异喹啉酮类化合物或其药物组合物在制备药物中的用途，所述药物用于预防或治疗与HIF相关或由HIF介导的疾病，例如贫血、缺血、局部缺血或缺氧等。